Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Notes Payables (2016 - 2025)

Healthy Extracts (HYEX) has 10 years of Notes Payables data on record, last reported at $110613.0 in Q3 2025.

  • For Q3 2025, Notes Payables fell 28.29% year-over-year to $110613.0; the TTM value through Sep 2025 reached $110613.0, down 28.29%, while the annual FY2024 figure was $2427.0, 99.33% down from the prior year.
  • Notes Payables reached $110613.0 in Q3 2025 per HYEX's latest filing, down from $240673.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $864750.0 in Q3 2021 and bottomed at $2427.0 in Q4 2024.
  • Average Notes Payables over 5 years is $372924.2, with a median of $332017.0 recorded in 2021.
  • Peak YoY movement for Notes Payables: surged 12711.11% in 2021, then plummeted 99.33% in 2024.
  • A 5-year view of Notes Payables shows it stood at $171750.0 in 2021, then skyrocketed by 84.74% to $317284.0 in 2022, then rose by 13.81% to $361093.0 in 2023, then tumbled by 99.33% to $2427.0 in 2024, then surged by 4457.6% to $110613.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $110613.0 in Q3 2025, $240673.0 in Q2 2025, and $493648.0 in Q1 2025.